BIOBOHEMIA
Pipeline
This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to the Privacy Policy and Terms of Use.
I accept
Close

Publications

Publications
See our latest publication
We are pleased to announce the release of our new scientific paper, which reveals the full potential of Biobohemia's Antigenic Essence technology platform and its prospects for cancer vaccines development.
Full text
See our latest publication
We are pleased to announce the release of our new scientific paper, which reveals the full potential of Biobohemia's Antigenic Essence technology platform and its prospects for cancer vaccines development.
Full text
"Changing Landscape of Cancer Vaccines—Novel Proteomics Platform for New Antigen Compositions"
2022, Int. J. Mol. Sci., 23(8), 4401
See publication
"Antigenic Essence: Upgrade of Cellular Cancer Vaccines"
2021, Cancers, 13 (4), 774
See publication
"SANTAVAC™: Summary of Research & Development"
2019, Vaccines, 7 (4), 186
See publication
"SANTAVAC™: A novel universal antigen composition for developing cancer vaccines"
2017, Recent Patents on Biotechnology, 11 (1): 32–41
See publication
"Allogeneic antigen composition for preparing universal cancer vaccines"
2016, Journal of Immunology Research, Article ID 5031529, PMID: 27781211
See publication
"Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC)"
2015, Human Vaccines & Immunotherapeutics, 11 (3): 689-698
See publication
"Universal cancer vaccine: an update on the design of cancer vaccines generated from endothelial cells"
2013, Human Vaccines & Immunotherapeutics, 9 (7): 1549-1552
See publication
"Tumor-induced endothelial cell surface heterogeneity directly affects endothelial cell escape from a cell-mediated immune response in vitro"
2013, Human Vaccines & Immunotherapeutics, 9 (1): 198-209
See publication
"Proteomic footprinting of drug-treated cancer cells as a measure of cellular vaccine efficacy for the prevention of cancer recurrence"
2012, Molecular & cellular proteomics, 11 (2): M111.014480
See publication
"Cellular Cancer Vaccines: an Update on the Development of Vaccines Generated from Cell Surface Antigens"
2010, Journal of Cancer, 1: 230-241
See publication
"Proteolytically-cleaved fragments of cell surface proteins stimulate a cytotoxic immune response against tumor-activated endothelial cells in vitro"
2010, Journal of Cancer Science & Therapy, 2: 126–131
See publication
"Proteolytically-cleaved fragments of cell-surface proteins from live tumor cells stimulate anti-tumor immune response in vitro"
2010, Journal of Carcinogenesis & Mutagenesis, 1: 1–3
See publication
"Cell proteomic footprint"
2009, Rapid Communications in Mass Spectrometry, 23: 680–682
See publication